{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:27:35Z","timestamp":1793845655675,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s10620-015-3629-5","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T04:59:45Z","timestamp":1427086785000},"page":"2436-2445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":174,"title":["Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease"],"prefix":"10.1007","volume":"60","author":[{"given":"Avegail","family":"Flores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezra","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisha J.","family":"Cipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Feagins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"3629_CR1","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785\u20131794.","journal-title":"Gastroenterology"},{"key":"3629_CR2","first-page":"1","volume":"82","author":"CL Ogden","year":"2012","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009\u20132010. NCHS Data Brief. 2012;82:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"3629_CR3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","volume":"303","author":"KM Flegal","year":"2010","unstructured":"Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999\u20132008. JAMA. 2010;303:235\u2013241.","journal-title":"JAMA"},{"key":"3629_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA. 2012;307:491\u2013497.","journal-title":"JAMA"},{"key":"3629_CR5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/00365528309182127","volume":"18","author":"H Both","year":"1983","unstructured":"Both H, Torp-Pedersen K, Kreiner S, Hendriksen C, Binder V. Clinical appearance at diagnosis of ulcerative colitis and Crohn\u2019s disease in a regional patient group. Scand J Gastroenterol. 1983;18:987\u2013991.","journal-title":"Scand J Gastroenterol"},{"key":"3629_CR6","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.308.6939.1259","volume":"308","author":"A Ferguson","year":"1994","unstructured":"Ferguson A, Sedgwick DM. Juvenile onset inflammatory bowel disease: height and body mass index in adult life. BMJ (Clinical research ed). 1994;308:1259\u20131263.","journal-title":"BMJ (Clinical research ed)"},{"key":"3629_CR7","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/ibd.21585","volume":"17","author":"MD Long","year":"2011","unstructured":"Long MD, Crandall WV, Leibowitz IH, et al. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:2162\u20132168.","journal-title":"Inflamm Bowel Dis"},{"key":"3629_CR8","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","volume":"7","author":"T Nic Suibhne","year":"2013","unstructured":"Nic Suibhne T, Raftery TC, McMahon O, Walsh C, O\u2019Morain C, O\u2019Sullivan M. High prevalence of overweight and obesity in adults with Crohn\u2019s disease: associations with disease and lifestyle factors. J Crohn\u2019s Colitis. 2013;7:e241\u2013e248.","journal-title":"J Crohn\u2019s Colitis"},{"key":"3629_CR9","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1097\/MIB.0b013e31829936a4","volume":"19","author":"GW Moran","year":"2013","unstructured":"Moran GW, Dubeau MF, Kaplan GG, Panaccione R, Ghosh S. The increasing weight of Crohn\u2019s disease subjects in clinical trials: a hypothesis-generatings time-trend analysis. Inflamm Bowel Dis. 2013;19:2949\u20132956.","journal-title":"Inflamm Bowel Dis."},{"key":"3629_CR10","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","volume":"54","author":"SE Wozniak","year":"2009","unstructured":"Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009;54:1847\u20131856.","journal-title":"Dig Dis Sci"},{"key":"3629_CR11","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409\u20132415.","journal-title":"J Clin Invest"},{"key":"3629_CR12","doi-asserted-by":"crossref","first-page":"e37160","DOI":"10.1371\/journal.pone.0037160","volume":"7","author":"JM Moreno-Navarrete","year":"2012","unstructured":"Moreno-Navarrete JM, Sabater M, Ortega F, Ricart W, Fernandez-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PloS One. 2012;7:e37160.","journal-title":"PloS One"},{"key":"3629_CR13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1054\/clnu.2001.0503","volume":"21","author":"A Blain","year":"2002","unstructured":"Blain A, Cattan S, Beaugerie L, Carbonnel F, Gendre JP, Cosnes J. Crohn\u2019s disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51\u201357.","journal-title":"Clin Nutr"},{"key":"3629_CR14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.cgh.2005.12.015","volume":"4","author":"DJ Hass","year":"2006","unstructured":"Hass DJ, Brensinger CM, Lewis JD, Lichtenstein GR. The impact of increased body mass index on the clinical course of Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2006;4:482\u2013488.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3629_CR15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10620-010-1541-6","volume":"56","author":"MA Mendall","year":"2011","unstructured":"Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn\u2019s disease? Dig Dis Sci. 2011;56:837\u2013844.","journal-title":"Dig Dis Sci"},{"key":"3629_CR16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jpedsurg.2013.11.033","volume":"49","author":"NP Zwintscher","year":"2014","unstructured":"Zwintscher NP, Horton JD, Steele SR. Obesity has minimal impact on clinical outcomes in children with inflammatory bowel disease. J Pediatr Surg. 2014;49:265\u2013268.","journal-title":"J Pediatr Surg"},{"key":"3629_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal world congress of gastroenterology. Can J Gastroenterol\u00a0=\u00a0Journal canadien de gastroenterologie. 2005;19:5\u201336.","journal-title":"Can J Gastroenterol\u00a0=\u00a0Journal canadien de gastroenterologie"},{"key":"3629_CR18","first-page":"3","volume":"16","author":"Z Bursac","year":"2008","unstructured":"Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.","journal-title":"Source Code Biol Med"},{"key":"3629_CR19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpeds.2007.04.004","volume":"151","author":"S Kugathasan","year":"2007","unstructured":"Kugathasan S, Nebel J, Skelton JA, et al. Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts. J Pediatr. 2007;151:523\u2013527.","journal-title":"J Pediatr"},{"key":"3629_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000262276","volume":"2","author":"H Steed","year":"2009","unstructured":"Steed H, Walsh S, Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts. 2009;2:370\u2013372.","journal-title":"Obes Facts"},{"key":"3629_CR21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ajg.2012.453","volume":"108","author":"SS Chan","year":"2013","unstructured":"Chan SS, Luben R, Olsen A, et al. Body mass index and the risk for Crohn\u2019s disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013;108:575\u2013582.","journal-title":"Am J Gastroenterol"},{"key":"3629_CR22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/01.mib.0000178915.54264.8f","volume":"11","author":"K Karmiris","year":"2005","unstructured":"Karmiris K, Koutroubakis IE, Kouroumalis EA. The emerging role of adipocytokines as inflammatory mediators in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:847\u2013855.","journal-title":"Inflamm Bowel Dis"},{"key":"3629_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gutjnl-2011-300370","volume":"61","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Gonzalez F, Dubuquoy L, et al. Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn\u2019s disease. Gut. 2012;61:78\u201385.","journal-title":"Gut"},{"key":"3629_CR24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrgastro.2009.222","volume":"7","author":"GR D\u2019Haens","year":"2010","unstructured":"D\u2019Haens GR. Top-down therapy for IBD: rationale and requisite evidence. Nat Rev Gastroenterol Hepatol. 2010;7:86\u201392.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3629_CR25","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1097\/MIB.0b013e31829cf401","volume":"19","author":"JW Harper","year":"2013","unstructured":"Harper JW, Sinanan MN, Zisman TL. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2118\u20132124.","journal-title":"Inflamm Bowel Dis"},{"key":"3629_CR26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04946.x","volume":"35","author":"E Bultman","year":"2012","unstructured":"Bultman E, de Haar C, van Liere-Baron A, et al. Predictors of dose escalation of adalimumab in a prospective cohort of Crohn\u2019s disease patients. Aliment Pharmacol Ther. 2012;35:335\u2013341.","journal-title":"Aliment Pharmacol Ther"},{"key":"3629_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jash.2012.11.008","volume":"7","author":"SG Chrysant","year":"2013","unstructured":"Chrysant SG, Chrysant GS. New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens JASH. 2013;7:85\u201394.","journal-title":"J Am Soc Hypertens JASH"},{"key":"3629_CR28","doi-asserted-by":"crossref","unstructured":"Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V. Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2011; 9:684\u2013687 e681.","DOI":"10.1016\/j.cgh.2011.05.005"},{"key":"3629_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11154-013-9236-x","volume":"14","author":"R Scalia","year":"2013","unstructured":"Scalia R. The microcirculation in adipose tissue inflammation. Rev Endocr Metab Disord. 2013;14:69\u201376.","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3629-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-3629-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-3629-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:40:15Z","timestamp":1566445215000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-3629-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["3629"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-3629-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}